Tiverton Asset Management’s ResMed RMD Stock Holding History

Tiverton Asset Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$442K	Sell	3,273 -1,534	-32%	-$201K	0.02%	419
2019 Q2	$587K	Sell	4,807 -2,450	-34%	-$271K	0.02%	350
2019 Q1	$755K	Buy	7,257 +5,346	+280%	+$552K	0.03%	280
2018 Q4	$218K	Hold	1,911	–	–	0.01%	301
2018 Q3	$220K	Buy	1,911 +37	+2%	+$4.05K	0.01%	316
2018 Q2	$194K	Sell	1,874 -94	-5%	-$9.51K	0.01%	320
2018 Q1	$194K	Buy	1,968 +63	+3%	+$5.95K	0.01%	320
2017 Q4	$161K	Buy	+1,905	New	+$157K	0.01%	415

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Tiverton Asset Management's RMD Position: Q3 2019 in Review

Tiverton Asset Management reduced its ResMed (RMD) stake by 32% in Q3 2019, selling an estimated $201K and leaving 3,273 shares worth $442K. The position accounts for 0.02% of the portfolio, ranked #419.

Tiverton Asset Management first reported a position in RMD in Q4 2017 and has held it in 8 quarters since. The position peaked at $755K in Q1 2019. 527 funds tracked by Wall St. Rank hold RMD as of Q3 2019.

Tiverton Asset Management held 3,273 shares of ResMed worth $442K as of Q3 2019.
Tiverton Asset Management sold 1,534 ResMed shares in Q3 2019, an estimated $201K.
ResMed made up 0.02% of Tiverton Asset Management's portfolio in Q3 2019, its #419 holding.
Tiverton Asset Management first reported a position in ResMed in Q4 2017 and has held it in 8 quarters since.
Tiverton Asset Management's ResMed position peaked at $755K in Q1 2019.
527 funds tracked by Wall St. Rank held ResMed as of Q3 2019.

Based on Tiverton Asset Management's 13F filing for Q3 2019, filed 13 Nov 2019.